Magnetothermally responsive drug-loaded micelles were designed and prepared for cancer therapy.
Introduction
Chemotherapy has been commonly used in cancer therapy. [1] [2] [3] [4] [5] However, its low efficiency and high side effects have been a major concern. More recently, combining chemotherapy with hyperthermia has shown a significant improvement in tumor treatment. It was reported that drug cytotoxicity was improved by hyperthermia in chemotherapy through reinforced permeability of the tumor vasculature. [6] [7] [8] [9] The traditional thermochemotherapy relies primarily on whole-body or local hyperthermia, which leads to low synchronism in drug delivery. [10] [11] [12] [13] [14] The synergistic effects of hyperthermia and chemotherapy need to be optimized on the tumor site. To address this critical issue, multifunctional thermo-responsive drug carriers have been designed and developed, utilizing the temperature-sensitive copolymers and magnetic nanoparticles (MNPs) with the magnetothermal effect. 15, 16 Both the sensitivity and delivery efficiency can be enhanced by optimizing the lower critical solution temperature (LCST) of the temperature-sensitive polymer and the hyperthermia temperature of MNPs containing the chemotherapeutic agent. Self-assembled copolymer nanoparticles have shown tremendous potential as chemotherapeutic drug-carriers. [17] [18] [19] As a new temperature-sensitive copolymer, poly(2-(2-methoxyethoxy)ethyl methacrylate-co-oligo(ethylene glycol)methacrylate) (P(MEO 2 MA-co-OEGMA)) was reported for its well-controlled LCST compared to the traditional temperature-sensitive copolymers, such as poly(N-isopropylacrylamide) (PNIPAM), which can be structurally modified by adjusting the ratio of co-monomers. 20 ,21 P(MEO 2 MA-co-OEGMA) also exhibits excellent biocompatibility, a crucial property in medical therapy. As a promising tumor treatment, magnetic fluid hyperthermia has been introduced for targeted heating in an alternating magnetic field (AMF). [22] [23] [24] [25] Furthermore, the magnetic fluid can be used as the contrast agent in magnetic resonance imaging, 26 therefore it is versatile in both diagnosis and treatment of cancer. [27] [28] [29] Compared with the most commonly used superparamagnetic iron oxide nanoparticles (SPIOs), many metal-doped spinel ferrites (MFe 2 O 4 , MvMn, Ni, Co, etc.) exhibit a higher saturated magnetization (M s ) and stronger MRI contrast effect in the T2-weighted images owing to the magneto-crystalline anisotropy. 30, 31 Meanwhile, a high specific absorption rate (SAR) is essential to the magnetic fluid for a better self-heating effect with a small amount of MNPs. In this study, magnetothermally responsive micelles were designed and prepared for cancer therapy. They were selfassembled from the temperature-sensitive star-block copolymers composed of hydrophobic poly(ε-caprolactone) (PCL) and hydrophilic P(MEO 2 MA-co-OEGMA). Manganese and zinc doped ferrite (MZF, Mn x Zn 1−x Fe 2 O 4 ) magnetic nanoparticles were encapsulated in the carrier system for magnetic hyperthermia heating. The LCST of micelles was accurately controlled by adjusting the ratio of MEO 2 MA to OEGMA, and optimized at 43°C. The magnetothermally responsive micelles loaded with the drug and MZF were investigated for growth inhibition of HepG2 cells under an AMF. The synergism of chemotherapy, magnetic hyperthermia, and the magnetothermally-facilitated drug release was also studied.
Experimental

Materials
The reagents, ε-caprolactone (CL), tin(II) 2-ethylhexanoate (Sn-(Oct) 2 ), 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), 2-bromoisobutyryl bromide, triethylamine, 2-(2-methoxyethoxy)ethyl methacrylate (MEO 2 MA), and oligo (ethylene glycol)methacrylate (OEGMA, M n = 475) were obtained from Sigma-Aldrich. N,N,N′,N″,N″-Pentamethyldiethylenetriamine (PMDETA) and dipentaerythritol were obtained from Acros Organics. A dialysis bag (molecular weight cut-off: 8000-14 000) was ordered from Sinopharm Chemical Reagent. Fetal bovine serum (FBS) was purchased from Hyclone. Trypsin-EDTA, penicillin-streptomycin, and high-glucose Dulbecco's modified Eagle's medium (DMEM) were purchased from Gibco.
CL was purified with CaH 2 for 48 h at room temperature and distilled under reduced pressure before use. Sn(Oct) 2 was distilled under reduced pressure. MEO 2 MA and OEGMA were passed through a column of activated basic alumina to remove inhibitors. Dipentaerythritol was dried in vacuo at 60°C for 24 h before use. Cuprous bromide (CuBr) was purified via stirring in acetic acid and washing with ethanol and then dried in a vacuum. 2-Bromoisobutyryl bromide was used without further purification.
Polymer synthesis and characterization
2.2.1 Synthesis of 6sPCL. Star-shaped poly(ε-caprolactone) (6sPCL) was synthesized by ring-opening polymerization (ROP) of CL using dipentaerythritol as an initiator and Sn(Oct) 2 as a catalyst. Typically, CL (41.09 g, 360 mmol), dipentaerythritol (0.60 g, 2.36 mmol) and a catalytic amount of Sn(Oct) 2 were added to a flame-dried polymerization tube. Argon gas was flushed through the tube three times until it was sealed.
Under magnetic stirring, polymerization was carried out at 115°C for 24 h under an argon atmosphere. The crude polymer was dissolved in dichloromethane and precipitated in cold methanol three times. The purified 6-arm polymer was dried in vacuo until a constant weight was obtained.
M 44 mmol) and THF (15 mL) were added in a dry Schlenk flask which was degassed with three freeze-evacuate-thaw cycles. MEO 2 MA and OEGMA were added into the reaction flask by using a syringe under an argon atmosphere. Polymerization was performed at 50°C for 5 h under magnetic stirring. The resulting product was dissolved in THF and passed through a basic alumina column to remove the copper catalysts. The polymer was obtained by precipitation into cold hexane and dried in vacuo at room temperature.
M n,NMR = 61 270, M n,GPC = 55 720, M w /M n = 1. 
Characterization methods
1 H NMR spectra were obtained with a Bruker DMX-500 1 H NMR spectrometer with CDCl 3 as the solvent. The chemical shifts for protons were determined with respect to tetramethylsilane (TMS) at δ = 0 ppm. Attenuated total reflection Fourier transform infrared (FTIR) spectra were recorded on an AVATAR-360 ESP FTIR spectrometer. The average molecular weight and its distribution were determined using a gel permeation chromatographic (GPC) system equipped with a Waters 150C separations module and a Waters differential refractometer. The polymer samples were dissolved in THF at a concentration of 1-2 mg mL −1 . THF was eluted at 1.0 mL min −1 through two Waters Styragel HT columns and a linear column. The morphology of copolymer micelles was studied using a transmission electron microscope (TEM, JEOL JEM-2010F, Japan) at an acceleration voltage of 120 kV. Briefly, a drop of micelles in a HEPES buffer solution was deposited on a copper grid. The sample was then stained with filtered phosphotungstic acid (PTA) before measurements.
Preparation and characterization of polymer micelles
2.4.1 Preparation and characterization of blank polymer micelles. Blank polymer micelles were prepared by dissolving the 6sPCL-b-P(MEO 2 MA-co-OEGMA) copolymer in THF and adding into water within 30 min dropwise with magnetic stirring. The mixture was dialyzed against ultrapure water by using a dialysis membrane (molecular weight cut-off: 8000-14 000 g mol −1 ) for 48 h. The water was refreshed every 6 h to remove the organic solvent. Finally the micellar solution was diluted into different concentrations with deionized water or a phosphate buffer solution (PBS, pH 7.4) for the following experiments. The size and the zeta potential of self-assembled micelles were determined at 25°C by using a Nano-ZS 90 Nanosizer (Malvern Instruments, Worcestershire, UK). The critical micelle concentration (CMC) of the star-block copolymer was determined with pyrene as a hydrophobic fluorescent probe. The concentration of the copolymer varied from 3.9 × 10 −3 mg mL −1 to 0.2 mg mL −1 and that of pyrene was fixed at 0.3 μM. Fluorescence spectra were recorded on a Hitachi F-2500 FL Spectrophotometer with the excitation wavelength of 334 nm. CMC was estimated by extrapolating the intensity of emission at 397 nm at low and high concentrations. 2.4.2 Preparation and characterization of self-assembled micelles encapsulated with the drug and MZF-MNPs. MZFs were prepared by the method of solution-phase thermal decomposition. [24] [25] [26] 33 Typical procedures of micelles encapsulated with the anti-tumor drug (DOX, doxorubicin) and MZF-MNPs (represented as DOX-MZF-micelles) are as follows. The 6sPCL-b-P(MEO 2 MA-co-OEGMA) copolymer and DOX were dissolved in THF, followed by adding a MZF/THF dispersion into the solution. After ultrasonication for 15 min, the mixture was transferred into a dialysis bag (molecular weight cut-off: 8000-14 000 g mol −1 ) and dialyzed against deionized water for 48 h. The water was refreshed every 6 h to remove the organic solvents. To remove unloaded MZF-MNPs, the solution was filtered through a 0.45 μm Millipore membrane filter. Finally, the remaining micellar solution was diluted to different concentrations with a phosphate buffer solution (PBS, pH 7.4). To determine the drug loading capacity, DOX-MZF-micelles were lyophilized for 48 h and dissolved in THF. The DOX amount was quantified by UV absorption at 478 nm against a standard calibration curve. The drug loading content (DLC) was defined by the equation: DLC (%) = (the mass of the drug loaded in micelles/the mass of drug loaded micelles) × 100%.
In vitro drug release behaviors
As a typical procedure, a 2.5 mL mixed micellar solution (1.0 mg mL for an additional 24 h with DOX-MZF-micelles. During this period, the cells were incubated at 37°C, and exposed to 43°C (5 min per 24 h) under an AMF ( f = 114 kHz, H applied = 89.9 kA m −1 , treated 5 min per 24 h) respectively. The HepG2 cells were subsequently fixed with paraformaldehyde (4%) for 30 min in an incubator and the cell nuclei were stained with a DAPI solution. The fluorescence images of HepG2 cells were obtained by confocal laser scanning microscopy (CLSM, TCS SP, Leica, Germany). NMR spectra of these block copolymers show all the proton signals, consistent with their expected chemical structures (Fig. 1C) . The peaks of methylene protons in PMEO 2 MA and POEGMA (f, h, i) are also detected. Methyl protons (g) appear at δ 0.88-1.04 ppm. GPC analysis further supports the successful preparation of the co-polymers (Fig. 2) . The GPC trace of 6sPCL-b-P(MEO 2 MA-co-OEGMA) indicates its monomodal and symmetric characteristics. Compared with 6sPCL and Scheme 1 Synthesis of star block copolymers by ring-opening polymerization (ROP) and atom transfer radical polymerization (ATRP). 6sPCL-Br, the elution peak of 6sPCL-b-P(MEO 2 MA-co-OEGMA) is shifted to a higher molecular weight as shown in Fig. 2 . FTIR spectra of the synthesized star-shaped polymers are shown in Fig. 3 . The peak at 3360-3580 cm −1 is the absorption band of the hydroxyl group and that at 1721 cm −1 is assigned to the absorption peak of the ester bond of PCL segments. From Fig. 3c , it can be seen that the relative intensities of the carbonyl bond absorptions at 1723 cm −1 are stronger than those of 6sPCL and 6sPCL-Br. Moreover, a new absorption peak at 1100 cm −1 appears in Fig. 3c , indicating the presence of the C-O-C bonds which exist in the MEO 2 MA-OEGMA copolymer. The new peak proves the successful introduction of MEO 2 MA and OEGMA. These results well characterize the structure of the 6sPCL-b-P(MEO 2 MA-co-OEGMA) block copolymer.
Results and discussion
3.2 Self-assembly behavior of 6sPCL-b-P(MEO 2 MA-co-OEGMA)
As shown in Fig. 4a , the MZF product was mainly monodisperse spherical nanocrystals with a relatively uniform diameter of 8 nm. The element ratio of Mn, Zn and Fe for MZF nanoparticles is 0.61/0.39/2 by inductively coupled plasma atomic emission spectroscopy (ICP-AES). With the hydrophobic PCL and hydrophilic P(MEO 2 MA-co-OEGMA) blocks, 6sPCL-b-P(MEO 2 MA-co-OEGMA) copolymers can spontaneously selfassemble into nanoscale micelles in PBS. The mixed micelles containing the drug and MZF-MNPs can be established by encapsulating hydrophobic DOX and MZF-MNPs into micellar cores physically. The blank polymer-, MZF-, and DOX-MZFmicelles prepared by a dialysis method were characterized by TEM, DLS, and fluorescence techniques. Typically, all these micelles exhibit a spherical morphology (Fig. 4) . The apparent radius of 6sPCL-b-P(MEO 2 MA-co-OEGMA) micelles observed by TEM is 115 nm (Fig. 4b) . Under a TEM, it is clear that MZF-MNPs are encapsulated by the polymer. As a consequence, the diameter of MZF-micelles increases to 180 nm (Fig. 4c) . Encapsulation of a hydrophobic drug results in further enlargement of DOX-MZF-micelles to 190 nm as shown in Fig. 4d .
The formation of micelles from the star-block copolymers was verified by a fluorescence probe technique using pyrene. As shown in Fig. 5 , the fluorescence intensity is approximately constant for a copolymer concentration of 47.7 mg L −1 . The intensity increases dramatically thereafter, indicating the formation of micelles and the transfer of pyrene molecules into the hydrophobic cores of the micelles. This concentration is defined as the critical micelle concentration (CMC). As shown in Fig. 5B , the 6sPCL-b-P(MEO 2 MA-co-OEGMA) micelles exhibit the lowest CMC value of 47.7 mg L −1 . 
Thermal phase transition properties of 6sPCL-b-P(MEO 2 MA-co-OEGMA)
The synthesized copolymer 6sPCL-b-P(MEO 2 MA-co-OEGMA) was assembled into nanoscale micelles in PBS. These micelles were formed from copolymers with different monomer feed ratios of MEO 2 MA to OEGMA (50 : 50, 60 : 40, 70 : 30, 80 : 20, 90 : 10, 100 : 0). As shown in Fig. 6a and b , LCSTs of the copolymer micelles in PBS are dependent on the compositions of MEO 2 MA and OEGMA. With the increase of the MEO 2 MA ratio, the LCST of micelles decreased linearly from 73.1°C to 37.3°C. In this way, LCST can be well predicted as shown in Fig. 6b . For example, a well-defined copolymer 6sPCL-b-P(MEO 2 MA-co-OEGMA) with a LCST of 43°C is to be synthesized from an initial monomer feed of 92% of MEO 2 MA. The LCST of the 6sPCL-b-P(MEO 2 MA92%-co-OEGMA8%) copolymer micelles (Fig. 6c ) is found to be close to the calculated value (Fig. 6b) . The hydrodynamic diameters (D h ) and size changes of 6sPCL-b-P(MEO 2 MA92%-co-OEGMA8%) micelles in aqueous solution were measured by DLS at different temperatures (Fig. 6d) . When the temperature is below the LCST, the D h values are small and change slightly. In contrast, the D h values increase in the higher temperature range.
In vitro drug release behaviour of DOX-MZF-micelles
The thermo-responsive properties of the 6sPCL-b-P(MEO 2 MAco-OEGMA) micelles can be used for drug release control. Doxorubicin (DOX) was used as the model drug to investigate the drug release behavior by thermo-responses of the micelles in PBS at pH 7.4. The drug loading content (DLC) of DOX-MZF-micelles was finally calculated to be 5.0% according to the method in section 2.4.2. As shown in Fig. 7 , significant changes in drug release near LCST of the copolymer are observed. At 25°C, a highly hydrated P(MEO 2 MA-co-OEGMA) segment stabilizes the hydrophobic-hydrophilic core-shell structure of the copolymer micelles. Only a small amount of the drug is found to diffuse outwardly from the micelles. The drug release is rather slow at this temperature, and 78% drug still remains in the micelles after 48 h. However, the micelles exhibit a higher release rate when the temperature is raised to 43°C. The P(MEO 2 MA-co-OEGMA) chains located on the shell of micelles become hydrophobic and the core-shell structure is deformed. The hydrophobic DOX incorporated into the core is diffused out quickly and more than 70% drug is released from the micelles. The release rate of the model drug DOX can be effectively controlled by changing the external temperatures. Due to the unique magnetic heating properties of DOX-MZF-micelles, the drug release by AMF is even more rapid than the conditions at 43°C. As shown in Fig. 7 , the cumulative DOX release of DOX-MZF-micelles reaches 35% rapidly in 5 min. Without an AMF, drug release of micelles slows down in the next 24 h. When an AMF is re-applied, the cumulative DOX release increased over 80%. Therefore, an AMF can effectively raise the temperature of micelles within a short time, leading to a faster thermal phase transition of micelles and more significant drug release.
The cytotoxicity of DOX under different treatments
The cytotoxicities of the blank-, MZF-, DOX-and DOX-MZFmicelles were investigated by the MTT assay and CLSM. As shown in Fig. 8 , the cell survival rates approximate 90% at the polymer concentrations ranging from 10 to 1000 μg mL −1 , indicating excellent biocompatibilities of the polymer-and MZF-micelles in HepG2 cells. Furthermore, the DOX-and DOX-MZF-micelles exhibit good inhibitory effects on the HepG2 cells at a low concentration (Fig. 9) .
To investigate the anti-tumor effects on the micelles under chemotherapy, thermo-chemotherapy, and magnetic thermochemotherapy, the DOX-MZF-micelles were incubated with HepG2 cells at 37°C as the chemotherapy control group, 43°C (5 min per 24 h) as the thermo-chemotherapy group, and AMF treatment (5 min per 24 h) as the magnetic hyperthermia- chemotherapy group for 24 h, 48 h and 72 h, respectively. The IC 50 value (the concentration that inhibited cell growth by 50%) was calculated simultaneously. At 37°C for 24 h, the IC 50 value of DOX-MZF-micelles was as high as 6.228 μg mL −1 .
After raising the temperature to 43°C, it decreased to 2.029 μg mL −1 , which was nearly one-third of that at 37°C. The notable reduction was mainly ascribed to the accelerated release of DOX. When the temperature reached the LCST of the drugloaded micelles, the phase transformation of thermo-responsive micelles took place leading to more pronounced drug release. High uptake of DOX is clearly observed in the CLSM images (Fig. 10) , showing the enhancement of anti-tumor efficiencies via hyperthermia. When treated with a periodic AMF (5 min per 24 h), the IC 50 value of DOX-MZF-micelles dra- matically decreased to 0.389 μg mL −1 , indicating that the cytotoxicity of DOX-MZF-micelles markedly enhanced by AMF. MZF-MNPs are able to rapidly raise the temperature of micelles above LCST owing to their unique temperature responsive properties under an AMF even at low concentrations. The physical encapsulation of MZF-MNPs in the DOX-MZF-micelles has also improved the heating efficiency of micelles in HepG2 cells. Comparing the IC 50 values under three different conditions for 24 h, 48 h and 72 h, the coefficients of synergism between the magnetic thermo-chemotherapy (under an AMF) and chemotherapy (at 43°C) are 5.22, 6.16 and 8.72, respectively. Furthermore, the synergism with increasing time can be seen in Fig. 11 , as a result of drug accumulation. The MTT and CLSM results clearly show the advantages of combining magnetic hyperthermia with magnetothermally-facilitated drug release, which leads to significant synergism of chemotherapy and hyperthermia.
Conclusions
In conclusion, we have synthesized the star-block copolymer 6sPCL-P(MEO 2 MA-co-OEGMA)s with different molar ratios of MEO 2 MA to OEGMA. The amphiphilic star copolymers have self-assembled to form nanoscale micelles with a CMC of 47.7 μg mL −1 . The LCST of the thermo-responsive micelles is well controlled at 43.5°C by adjusting the content of MEO 2 MA. The hydrophobic DOX and MZF-MNPs are efficiently encapsulated into micelles that facilitate in vitro DOX release from DOX-MZF-micelles at the temperature above LCST. The DOX-MZF-micelles show enhanced growth inhibition on HepG2 cells under an AMF. These magnetothermally responsive star-block copolymeric micelles can potentially be used in efficient drug delivery and effective thermochemotherapy.
